A study presented at RSNA 2024 demonstrated findings at midlife, decades prior to patients exhibiting early symptoms of Alzheimer's disease related dementia.
"If the pharmaceutical industry had developed a single drug capable of reducing cancer mortality by 25%, autoimmune disorders by 39%, and COVID-19 infection rates by 74%, it would be heralded as a miracle drug."
A 10-year Finnish study found insulin resistance biomarkers were associated with increased aortic stenosis risk, with hazard ratios ranging from 1.38 to 1.47, independent of age, BMI, and hypertension.
COVID-19 was associated with a myocarditis rate of 0.73 per 1,000 person-years compared to 0.24 for influenza, with young males showing the highest rates.